Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
nCaF2 Primer for WSL Prevention in Orthodontics
NCT04994314Phase 3Unknown
- Sponsor
- University of Baghdad
- Start
- Feb 2021
- Primary completion
- Dec 2021
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in White spot lesion (WSL) (2 arms), sponsored by University of Baghdad. Primary endpoint: DIAGNOdent Pen scores change at 6 months. Status: unknown.
02
Conditions
White spot lesion (WSL)
Beyond the preview
Go deeper on NCT04994314.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04994314.